Komori
Anest Iwata (6381) · RiskReframed

Delayed Response to Technological Innovation and Regulatory Changes

First written in FY2017. 2 of 5 entries say "Restated". Latest entry: FY2025.

5entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2019WorsenedFY2021RestatedFY20232017: 120172018: 020182019: 120192020: 020202021: 120212022: 020222023: 120232024: 020242025: 12025
Same theme, other companies
Risk of delays in developing products to address changes in laws and regulationsA theme 3 companies write about · 3 as a headwind · 0 as a tailwind

Anest Iwata moved to the "Worse" side of this theme in 2025.

0 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025ReframedAnnual report

    「Specifically, the areas covered are wide-ranging, including import and export controls, product safety, intellectual property rights, working conditions and personal information protection, as well as consideration for human rights and the environment across the Group’s own business activities and the entire supply chain.」

    The scope of disclosure was expanded from the existing risk of delayed responses to technological innovation and environmental regulations to the risk of responding to global regulations generally, including those concerning imports and exports, product safety, intellectual property, labor, personal information, human rights and the environment.
  2. FY2023RestatedAnnual report

    「As awareness of the global environment and climate change rises worldwide, Japan and other countries are tending to introduce new environmental regulations and tighten existing ones.」

    The risk of business impacts from the introduction and tightening of environmental and climate-related regulations and delays in launching compliant products continues to be disclosed.
  3. FY2021WorsenedAnnual report

    「As awareness of environmental issues rises globally, Japan and other countries are tending to introduce new environmental regulations and tighten existing ones. Delays in complying with regulations or launching products that meet these regulations could restrict business activities or result in lost revenue opportunities, potentially adversely affecting the Group’s business and operating results.」

    The description of the existing risk of delayed responses to technological innovation and environmental regulations was expanded to specify the effects of new and stricter environmental regulations and delays in product launches.
  4. FY2019RestatedAnnual report

    「If the Group’s products and services are unable to keep pace with the rapid speed of technological innovation, including IT, and external factors such as regulatory changes progressing around the world, as well as changes in economic and market conditions, this may affect the Group’s financial position and operating results.」

    The risk of delayed responses to technological innovation, IT developments and regulatory changes continues to be disclosed.
  5. FY2017First statedAnnual report

    「If the Group’s products and services are unable to keep pace with the rapid speed of technological innovation in recent years and external factors such as regulatory changes progressing around the world, this may affect the Group’s financial position and operating results.」

    The risk that product and service innovation may fail to keep pace with technological innovation and regulatory developments is disclosed as a standalone item for the first time.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Anest Iwata yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Delayed Response to Technological Innovation and Regulatory Changes | ANEST IWATA Corporation (6381) | Komori